Additional file 1: of Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/GinkgoselectÂŽPlus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]

Bonassi, Stefano; Prinzi, Giulia; Lamonaca, Palma; Russo, Patrizia; Paximadas, Irene; Rasoni, Giuseppe; Rossi, Raffaella; Ruggi, Marzia; Malandrino, Salvatore; SĂĄnchez-Flores, Maria; Valdiglesias, Vanessa; Benassi, Barbara; Pacchierotti, Francesca; Villani, Paola; Panatta, Martina; Cordelli, Eugenia

doi:10.6084/m9.figshare.5812266.v1

12906_2018_2080_MOESM1_ESM.pdf (622.71 kB)

Additional file 1: of Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/GinkgoselectÂŽPlus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]

journal contribution

posted on 2018-01-22, 05:00 authored by Stefano Bonassi, Giulia Prinzi, Palma Lamonaca, Patrizia Russo, Irene Paximadas, Giuseppe Rasoni, Raffaella Rossi, Marzia Ruggi, Salvatore Malandrino, Maria SĂĄnchez-Flores, Vanessa Valdiglesias, Barbara Benassi, Francesca Pacchierotti, Paola Villani, Martina Panatta, Eugenia Cordelli

Certificate. Analysis Certificate of IDN 5933/GinkgoselectÂŽPlus and placebo [LM42506]. Indena S.p.A. declares all components used for the preparation of products. (PDF 622 kb)

Funding

Indena SpA

History

Usage metrics

Keywords

Ginkgo biloba Extract Safety Genomic stability DNA cell maintenance

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/GinkgoselectÂŽPlus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]

Funding

Indena SpA

History

Usage metrics

Categories

Keywords

Licence

Exports